跳至主要内容
临床试验/NCT06931860
NCT06931860Enrolling By Invitation不适用

Comparative Effectiveness of Mailed Cologuard Outreach to Mailed FIT Outreach

University of California, San Diego1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2025年9月5日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
400
试验地点
1
主要终点
Proportion of Colorectal cancer screening completion

研究概览

简要总结

The objective of this study is to measure the comparative effectiveness of mailed outreach of two stool based tests, multi-target stool DNA (Cologuard) and the fecal immunochemical test (FIT) in screening eligible adults ages 45-49 receiving care at the University of California San Diego Health system.

详细描述

Adults ages 45-49 who are insured, deemed average risk and not currently up to date with colorectal cancer screening will be enrolled. Eligible participants will be randomized to either mailed Cologuard outreach, facilitated by Exact Sciences or mailed FIT outreach. Colorectal cancer screening completion within 12 months of randomization will be measured as the primary outcome, in addition to secondary outcomes of Cologuard or FIT positivity rate measured within 12 months of randomization, and follow-up colonoscopy uptake and CRC incidence, measured within 24 months of randomization.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
45 Years 至 49 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults ages 45-49 with EHR documentation indicating that the patient has an assigned primary care provider at UCSD Health
  • •≥1 UCSD Health System health visit within the last year
  • •Resides in San Diego or Imperial County
  • •Currently not up to date with CRC screening
  • •Insured by private, public or other health insurance.

排除标准

  • •Up-to-date with screening
  • •Prior history of colonic disease, including inflammatory bowel disease, one or more colorectal neoplastic polyps (i.e., adenomas) or colorectal cancer.
  • •Prior history of colectomy
  • •Lack of health insurance

研究组 & 干预措施

Mailed Cologuard Outreach

Experimental

Receipt of mailed Cologuard test for colorectal cancer screening to be completed and returned by participant. If test is negative, participant will be advised to undergo another test in 3 years. If test is positive, participant will be advised to schedule colonoscopy for further testing.

干预措施: Cologuard (Diagnostic Test)

Mailed Fecal immunochemical test Outreach

Experimental

Receipt of mailed FIT for colorectal cancer screening to be completed and returned by participant. If test is negative, participant will be advised to undergo another test in 1 year. If test is positive, participant will be advised to schedule colonoscopy for further testing.

干预措施: Fecal Immunochemical Test (Diagnostic Test)

结局指标

主要结局

Proportion of Colorectal cancer screening completion

时间窗: Within 12 months of randomization

The proportion of individuals who complete any colorectal cancer screening test recommended by US Preventive Services Task Force (colonoscopy, FIT, Cologuard, Sigmoidoscopy or CT Colonography)

次要结局

  • Proportion of Abnormal stool blood test results(Within 12 months of randomization)
  • Proportion of Follow-up colonoscopy after abnormal stool blood test result(Within 24 months after randomization)
  • Colorectal cancer incidence(Within 24 months after randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joshua Demb, PhD, MPH

Assistant Professor

University of California, San Diego

研究点 (1)

Loading locations...

相似试验